The effects of olanzapine on Alzheimer's disease assessment scale scores in patients with mild to moderate Alzheimer's disease with psychosis and behavioral disturbances

被引：0
|
作者：
Kennedy, JS [1 ]
Basson, B [1 ]
Clark, WS [1 ]
Sanger, TM [1 ]
Stauffer, V [1 ]
Street, JS [1 ]
Tollefson, GD [1 ]
Zagar, A [1 ]
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
BIOLOGICAL PSYCHIATRY | 2001年 / 49卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
378
引用
收藏
页码：108S / 109S
页数：2
相关论文
共 50 条
  • [21] The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
    Hartry, Ann
    Aldhouse, Natalie
    Al-Zubeidi, Tamara
    Sanon, Myrlene
    Stefanacci, Richard
    Knight, Sarah
    QUALITY OF LIFE RESEARCH, 2018, 27 : S21 - S22
  • [22] The Alzheimer's disease assessment scale: Evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease
    Doraiswamy, PM
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 (01): : 48 - 48
  • [23] The Alzheimer's disease assessment scale: Evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease
    Doraiswamy, PM
    Kaiser, L
    Bieber, F
    Garman, RL
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2001, 15 (04): : 174 - 183
  • [24] Olanzapine in the treatment of psychiatric disturbances associated with Alzheimer's disease
    Street, J
    Clark, WS
    Mitan, S
    Tamura, T
    Kadam, D
    Sanger, T
    Gannon, KS
    Tollefson, GD
    NEUROLOGY, 1999, 52 (06) : A396 - A397
  • [25] The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease
    Clark, WS
    Street, JS
    Feldman, PD
    Breier, A
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (01) : 34 - 40
  • [26] Brief Behavioral Activation Therapy is effective on apathy symptoms of the older adults with mild Alzheimer's disease but not with moderate Alzheimer's disease
    Karimpourvazifehkhorani, Alireza
    Hekmati, Issa
    Rezvanizadeh, Akram
    Amiri, Nahideh
    Kadkhoda, Milad
    Arasteh, Farnoush
    AGING & MENTAL HEALTH, 2025,
  • [27] Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's dementia
    De Deyn, PP
    Carrasco, MM
    Deberdt, W
    Jeandel, C
    Hay, DP
    Feldman, PF
    Young, CA
    Lehman, DL
    Breier, A
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A57 - A57
  • [28] Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's dementia
    Hoffmann, VP
    DeDeyn, PP
    Carrasco, MM
    Deberdt, W
    Jeandel, C
    Hay, DP
    Feldman, PD
    Young, CA
    Lehman, DL
    Breier, A
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 337 - 337
  • [29] Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's dementia
    De Deyn, PP
    Carrasco, MM
    Deberdt, W
    Jeandel, C
    Hay, DP
    Feldman, PD
    Young, CA
    Lehman, DL
    Breier, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S345 - S345
  • [30] Effects of galantamine in patients with mild Alzheimer's disease
    Orgogozo, JM
    Small, GW
    Hammond, G
    Van Baelen, B
    Schwalen, S
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (11) : 1815 - 1820
12345